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Abstract
Neuropeptide Y (NPY) receptors (nomenclature as agreed by the NC-IUPHAR Subcommittee on
Neuropeptide Y Receptors [156]) are activated by the endogenous peptides neuropeptide Y, neuropeptide Y-
(3-36), peptide YY, PYY-(3-36) and pancreatic polypeptide (PP). The receptor originally identified as the Y3
receptor has been identified as the CXCR4 chemokine recepter (originally named LESTR, [137]). The y6
receptor is a functional gene product in mouse, absent in rat, but contains a frame-shift mutation in primates
producing a truncated non-functional gene [83]. Many of the agonists exhibit differing degrees of selectivity
dependent on the species examined. For example, the potency of PP is greater at the rat Y4 receptor than at the
human receptor [61]. In addition, many agonists lack selectivity for individual subtypes, but can exhibit
comparable potency against pairs of NPY receptor subtypes, or have not been examined for activity at all
subtypes. [125I]-PYY or [125I]-NPY can be used to label Y1, Y2, Y5 and y6 subtypes non-selectively, while [125I]
[cPP(1-7), NPY(19-23), Ala31, Aib32, Gln34]hPP may be used to label Y5 receptors preferentially (note that cPP
denotes chicken peptide sequence and hPP is the human sequence).
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